Medical News
Risk Factors for Small-bowel Obstruction after Colectomy for...
Surg. Today
Tumor localization in the rectum is associated with several problems, including a wide resection area, prolonged...
23 Mar 2023
Association of NLR with Survival in Peripheral Early-stage N...
BMC Cancer
Pretreatment NLR is an independent predictor for survival outcomes of peripheral early-stage non-small cell Lung...
20 Mar 2023
Efficacy and Safety of Immune Checkpoint Inhibitors in Elder...
Cancer Immunol. Immunother.
The results indicated that immune checkpoint inhibitors might exhibit better efficacy in the elderly with primary...
09 Mar 2023
Survival Outcomes Between Neoadjuvant and Adjuvant Chemother...
Breast Cancer
The opposite trends (before multiple testing adjustment) of survival comparisons for advanced HER2 + and triple-...
27 Feb 2023
eCMEs
Our Publications
Pomalong (Pomalidomide) Monograph
Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.
Q & A on Imatinib- Focused on CML
Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...
Q & A on Imatinib- Focused on GIST
Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...
Slide Library
Management of Advanced Prostate Cancer: Current Concepts
Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India. Hormonal therapy or androgen...
Clinical Appraisal of Abiraterone acetate in Management of CRPC
Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...
HBV Reactivation in Patients Undergoing Chemotherapy
The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...
Paclitax NAB (Nanoparticle Albumin Bound Paclitaxel)
Nanoparticle Albumin Bound Paclitaxel is indicated for second line therapy for metastatic breast cancer. This slide set includes information on...
Key Trials
PALOMA 3 Trial: Efficacy of Fulvestrant ± Palbociclib in Treatment of HER2-negative Breast Cancer
PALOMA 3 Trial demonstrated significant improvement in progression free survival with combination of fulvestrant plus Palbociclib compared with...
PALOMA 2 Trial: Efficacy and Safety of Palbociclib plus Letrozole for Postmenopausal Women with Advanced Breast Cancer
PALOMA 2 trial showed that the addition palbociclib with letrozole significantly improved outcomes in the first-line treatment of ER-positive, HER2-...
Efficacy and Safety of Low-Dose BCG vs Standard-Dose BCG in NMIBC
Although low-dose BCG had higher recurrence rate than standard-dose BCG, tumor progression, cancer-specific survival, and overall survival were...
Efficacy and Safety of Pazopanib Monotherapy in Treatment-naive and cytokine-pre-treated Patients with Advanced and/or Metastatic RCC
This study investigated efficacy and safety of pazopanib monotherapy in treatment-naive and cytokine-pre-treated patients with advanced and/or...
Patient Education
All You Need to Know About Erlotinib
Erlotinib is a indicated for Lung and Pancreatic cancer. This input describes Erlotinib administration & possible side effects.
All You Wanted to Know About Thyroid Cancer
Thyroid cancer is relatively uncommon compared to other cancers. This input describes the risk factors, symptoms, diagnosis and over all treatment fo...
All You Wanted to Know about Prostate Cancer
Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...
Living with Leukemia/Lymphoma
Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding.
.jpg)
Poll
Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
Capecitabine
Tegafur uracil
5-FU
Total votes: 10